Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Scotts Miracle-Gro Issues FY13 Guidance

RELATED NEWS
Trade SMG now with 

Scotts Miracle-Gro Co. (SMG: Quote) Friday provided a financial guidance for the full year 2013. The mid-point of the earnings outlook is expected beat current Street estimates, while revenues are anticipated to fall short of expectations.

The Marysville, Ohio-based company expects adjusted earnings from continuing operations of $2.50 to $2.75 per share. Analysts polled by Thomson Reuters currently estimate earnings of $2.55 per share for the year. Analysts' estimates typically exclude one-time items.

Scotts Miracle-Gro expects full-year 2013 sales to grow about 1 to 3 percent on flat unit volume and improved pricing. This indicates revenues of $2.86 billion to $2.91 billion. Analysts currently estimate revenues of $2.91 billion for the year.

Scotts Miracle-Gro, a maker of lawn and garden care products, anticipates gross margin rate to improve with leverage in selling, general and administrative costs. Operating margin is expected to be in the range of 11 to 11.5 percent.

"We enter 2013 with confidence in our initiatives to drive gross margin improvement, reduce SG&A, improve cash flow and strengthen the overall enterprise," said Jim Hagedorn, chairman and chief executive officer.

SMG is currently trading at $42.97, up $1.12 or 2.68%, on the NYSE.

Register
To receive FREE breaking news email alerts for The Scotts Miracle-Gro Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.